Gene Therapy for HIV Infections: Intracellular Immunization

Despite significant advances in the treatment of human immunodeficiency virus (HIV) infection in the past 10 years, it remains an incurable disease. The inability of traditional drug-based therapies to inhibit HIV replication effectively for extended periods of time has stimulated intense research t...

Full description

Saved in:
Bibliographic Details
Main Author: Alain Piché
Format: Article
Language:English
Published: Wiley 1999-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1999/914379
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566887978893312
author Alain Piché
author_facet Alain Piché
author_sort Alain Piché
collection DOAJ
description Despite significant advances in the treatment of human immunodeficiency virus (HIV) infection in the past 10 years, it remains an incurable disease. The inability of traditional drug-based therapies to inhibit HIV replication effectively for extended periods of time has stimulated intense research to develop novel approaches for this disease. Current understanding of HIV molecular biology and pathogenesis has opened the way for the development of gene therapy strategies for HIV infections. In this context, a number of intracellular immunization-based strategies have been evaluated, and some of them have reached the stage of phase I/II human clinical trials. These strategies include the use of single-chain antibodies, capsid-targeted viral inactivation, transdominant negative mutants, ribozymes, antisense oligonucleotides and RNA decoys. While a number of issues remain to be studied before intracellular immunization can be applied to the treatment of HIV infections, the significant progress already made in this field is likely to lead to clinical applications.
format Article
id doaj-art-4399a9e2664941dea1bdfee8791e46f1
institution Kabale University
issn 1180-2332
language English
publishDate 1999-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases
spelling doaj-art-4399a9e2664941dea1bdfee8791e46f12025-02-03T01:02:52ZengWileyCanadian Journal of Infectious Diseases1180-23321999-01-0110430731210.1155/1999/914379Gene Therapy for HIV Infections: Intracellular ImmunizationAlain Piché0Département de Microbiologie, Université de Sherbrooke, Sherbrooke, Québec, CanadaDespite significant advances in the treatment of human immunodeficiency virus (HIV) infection in the past 10 years, it remains an incurable disease. The inability of traditional drug-based therapies to inhibit HIV replication effectively for extended periods of time has stimulated intense research to develop novel approaches for this disease. Current understanding of HIV molecular biology and pathogenesis has opened the way for the development of gene therapy strategies for HIV infections. In this context, a number of intracellular immunization-based strategies have been evaluated, and some of them have reached the stage of phase I/II human clinical trials. These strategies include the use of single-chain antibodies, capsid-targeted viral inactivation, transdominant negative mutants, ribozymes, antisense oligonucleotides and RNA decoys. While a number of issues remain to be studied before intracellular immunization can be applied to the treatment of HIV infections, the significant progress already made in this field is likely to lead to clinical applications.http://dx.doi.org/10.1155/1999/914379
spellingShingle Alain Piché
Gene Therapy for HIV Infections: Intracellular Immunization
Canadian Journal of Infectious Diseases
title Gene Therapy for HIV Infections: Intracellular Immunization
title_full Gene Therapy for HIV Infections: Intracellular Immunization
title_fullStr Gene Therapy for HIV Infections: Intracellular Immunization
title_full_unstemmed Gene Therapy for HIV Infections: Intracellular Immunization
title_short Gene Therapy for HIV Infections: Intracellular Immunization
title_sort gene therapy for hiv infections intracellular immunization
url http://dx.doi.org/10.1155/1999/914379
work_keys_str_mv AT alainpiche genetherapyforhivinfectionsintracellularimmunization